Abstract
Get full access to this article
View all access options for this article.
References
1.
Soelberg
KK
,
Bonnema
SJ
,
Brix
T
,
Hegedus
L
. 2012 . Risk of malignancy in thyroid incidentalomas detected by 18F-fluorodeoxyglucose positron emission tomography. A systematic review . Thyroid , 22 :918 –925 .
2.
Abraham
T
,
Schöder
H
. 2011 . Thyroid cancer—indications and opportunities for positron emission tomography/computed tomography imaging . Semin Nucl Med , 41 :121 –138 .
3.
Boellaard
R
,
O'Doherty
MJ
,
Weber
WA
,
Mottaghy
FM
,
Lonsdale
MN
,
Stroobants
SG
,
Oyen
WJ
,
Kotzerke
J
,
Hoekstra
OS
,
Pruim
J
,
Marsden
PK
,
Tatsch
K
,
Hoekstra
CJ
,
Visser
EP
,
Arends
B
,
Verzijlbergen
FJ
,
Zijlstra
JM
,
Comans
EF
,
Lammertsma
AA
,
Paans
AM
,
Willemsen
AT
,
Beyer
T
,
Bockisch
A
,
Schaefer-Prokop
C
,
Delbeke
D
,
Baum
RP
,
Chiti
A
,
Krause
BJ
. 2010 . FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0 . Eur J Nucl Med Mol Imaging , 37 :181 –200 .
4.
Kinahan
PE
,
Fletcher
JW
. 2010 . Positron emission tomography-computed tomography standardized uptake values in clinical practice and assessing response to therapy . Semin Ultrasound CT MR , 31 :496 –505 .